• 1
    Pulte D,Gondos A,Brenner H. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 2009; 113: 14081411.
  • 2
    Wood WA,Lee SJ. Malignant hematologic diseases in adolescents and young adults. Blood 2011; 117: 58035815.
  • 3
    Schafer ES,Hunger SP. Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults. Nat Rev Clin Oncol 2011; 8: 417424.
  • 4
    Ribera JM,Oriol A. Acute lymphoblastic leukemia in adolescents and young adults. Hematol Oncol Clin North Am 2009; 23: 10331042, vi.
  • 5
    Tricoli JV,Seibel NL,Blair DG, et al. Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst 2011; 103: 628635.
  • 6
    Ramanujachar R,Richards S,Hann I,Webb D. Adolescents with acute lymphoblastic leukaemia: Emerging from the shadow of paediatric and adult treatment protocols. Pediatr Blood Cancer 2006; 47: 748756.
  • 7
    Burke ME,Albritton K,Marina N. Challenges in the recruitment of adolescents and young adults to cancer clinical trials. Cancer 2007; 110: 23852393.
  • 8
    Stroup DF,Berlin JA,Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 20082012.
  • 9
    Berlin JA,Rennie D. Measuring the quality of trials: The quality of quality scales. JAMA 1999; 282: 10831085.
  • 10
    DerSimonian R,Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177188.
  • 11
    Stock W,La M,Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood 2008; 112: 16461654.
  • 12
    Ramanujachar R,Richards S,Hann I, et al. Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer 2007; 48: 254261.
  • 13
    Hallbook H,Gustafsson G,Smedmyr B, et al. Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: A comparison between a pediatric protocol and an adult protocol. Cancer 2006; 107: 15511561.
  • 14
    de Bont JM,Holt B,Dekker AW, et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia 2004; 18: 20322035.
  • 15
    Boissel N,Auclerc MF,Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003; 21: 774780.
  • 16
    Usvasalo A,Raty R,Knuutila S, et al. Acute lymphoblastic leukemia in adolescents and young adults in Finland. Haematologica 2008; 93: 11611168.
  • 17
    Huguet F,Leguay T,Raffoux E, et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: The GRAALL-2003 study. J Clin Oncol 2009; 27: 911918.
  • 18
    Lopez-Hernandez MA,Alvarado-Ibarra M,Jimenez-Alvarado RM, et al. Adolescents with de novo acute lymphoblastic leukemia: Efficacy and safety of a pediatric vs adult treatment protocol. Gac Med Mex 2008; 144: 485489.
  • 19
    Barisone E,Vivenza C,Oderda S, et al. [Acute lymphoblastic leukemia in adolescents]. Minerva Pediatr 1995; 47: 277283.
  • 20
    Cairo MS,Gerrard M,Sposto R, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood 2007; 109: 27362743.
  • 21
    Chang JE,Medlin SC,Kahl BS, et al. Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia. Leuk Lymphoma 2008; 49: 22982307.
  • 22
    Colovic M,Bogdanovic A,Jankovic G, et al. Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol. Chemotherapy 2003; 49: 138145.
  • 23
    Koharazawa H,Kanamori H,Sakai R, et al. Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia. Leuk Lymphoma 2008; 49: 21332140.
  • 24
    Nachman JB,La MK,Hunger SP, et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: A report from the children's oncology group. J Clin Oncol 2009; 27: 51895194.
  • 25
    Ribera JM,Oriol A,Sanz MA, et al. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanol de Tratamiento en Hematologia pediatric-based protocol ALL-96. J Clin Oncol 2008; 26: 18431849.
  • 26
    Schroder H,Kjeldahl M,Boesen AM, et al. Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark-secondary publication. Dan Med Bull 2006; 53: 7679.
  • 27
    Schroder H,Kjeldstad M,Boesen AM, et al. Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children? Ugeskr Laeger 2006; 168: 25542558.
  • 28
    Alves M,Daudt L,Mazzucco KLM, et al. Is it better to treat adolescents with acute lymphoblastic leukemia as old children or as young adults? ASH Annual Meeting Abstracts 2008; 112: 3968.
  • 29
    Haiat S,Vekhoff A,Marzac C, et al. Improved outcome of adult acute lymphoblastic leukemia treated with a pediatric protocol: Results of a pilot study. Blood 2007;110: abstract 2822.
  • 30
    Testi AM,Valsecchi MG,Conter V, et al. Difference in outcome of adolescents with acute lymphoblastic leukemia (ALL) enrolled in pediatric (AIEOP) and adult (GIMEMA) protocols. Blood 2004;104; abstract 1954.
  • 31
    Stock W. Adolescents and young adults with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2010; 2010: 2129.
  • 32
    Pui CH,Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166178.
  • 33
    Moorman AV,Harrison CJ,Buck GA, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 2007; 109: 31893197.
  • 34
    Pullen J,Shuster JJ,Link M, et al. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia 1999; 13: 16961707.
  • 35
    Secker-Walker LM,Craig JM,Hawkins JM,Hoffbrand AV. Philadelphia positive acute lymphoblastic leukemia in adults: Age distribution, BCR breakpoint and prognostic significance. Leukemia 1991; 5: 196199.
  • 36
    Aguiar RC,Sohal J,van Rhee F, et al. TEL-AML1 fusion in acute lymphoblastic leukaemia of adults. M.R.C. Adult Leukaemia Working Party. Br J Haematol 1996; 95: 673677.
  • 37
    Harrison CJ. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol 2009; 144: 147156.
  • 38
    Patel B,Richards SM,Rowe JM, et al. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: A UKALL XII analysis. Leukemia 2008; 22: 308312.
  • 39
    Hunault-Berger M,Chevallier P,Delain M, et al. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study. Haematologica 2008; 93: 14881494.
  • 40
    Nachman J,Sather HN,Buckley JD, et al. Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment. Cancer 1993; 71: 33773385.